From Revolv Flips Switch on its Smart Hub to Unite Home Automation Devices:

Revolv Smart Home Solution—

Revolv is a Colorado startup that sells a hub designed to let users control smart devices made by different manufacturers with one iPhone or iPad app.

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Kaleido Bio CEO Lawton Resigns; Company Plans Search for Successor

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Revolv Flips Switch on its Smart Hub to Unite Home Automation Devices:

Underwriters and Partners

The Bay Area and Beyond: Biocom Talks Innovation and COVID

How to Approach Life Sciences Fundraising

Containing Coronavirus Through Innovation and Investment

Xconomy on Demand

We offer a number of ways to subscribe for free!